Junn E - Search Results

1

Nucleic Acid-Based Therapeutics for Parkinson's Disease.

Nakamori M, Junn E, Mochizuki H, Mouradian MM. Nakamori M, et al. Among authors: junn e. Neurotherapeutics. 2019 Apr;16(2):287-298. doi: 10.1007/s13311-019-00714-7. Neurotherapeutics. 2019. PMID: 30756362 Free PMC article. Review.

2

Three-amino acid extension loop homeodomain proteins Meis2 and TGIF differentially regulate transcription.

Yang Y, Hwang CK, D'Souza UM, Lee SH, Junn E, Mouradian MM. Yang Y, et al. Among authors: junn e. J Biol Chem. 2000 Jul 7;275(27):20734-41. doi: 10.1074/jbc.M908382199. J Biol Chem. 2000. PMID: 10764806 Free article.

3

PQBP-1/Npw38, a nuclear protein binding to the polyglutamine tract, interacts with U5-15kD/dim1p via the carboxyl-terminal domain.

Waragai M, Junn E, Kajikawa M, Takeuchi S, Kanazawa I, Shibata M, Mouradian MM, Okazawa H. Waragai M, et al. Among authors: junn e. Biochem Biophys Res Commun. 2000 Jul 5;273(2):592-5. doi: 10.1006/bbrc.2000.2992. Biochem Biophys Res Commun. 2000. PMID: 10873650

4

ZIC2 and Sp3 repress Sp1-induced activation of the human D1A dopamine receptor gene.

Yang Y, Hwang CK, Junn E, Lee G, Mouradian MM. Yang Y, et al. Among authors: junn e. J Biol Chem. 2000 Dec 8;275(49):38863-9. doi: 10.1074/jbc.M007906200. J Biol Chem. 2000. PMID: 10984499 Free article.

5

Characterization of the 5' flanking region of the rat D(3) dopamine receptor gene.

D'Souza UM, Wang W, Gao DQ, Kanda S, Lee G, Junn E, Hwang CK, Jose PA, Mouradian MM. D'Souza UM, et al. Among authors: junn e. J Neurochem. 2001 Mar;76(6):1736-44. doi: 10.1046/j.1471-4159.2001.00155.x. J Neurochem. 2001. PMID: 11259491 Free article.

6

Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases.

Junn E, Mouradian MM. Junn E, et al. J Neurochem. 2001 Jul;78(2):374-83. doi: 10.1046/j.1471-4159.2001.00425.x. J Neurochem. 2001. PMID: 11461973 Free article.

7

Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine.

Junn E, Mouradian MM. Junn E, et al. Neurosci Lett. 2002 Mar 8;320(3):146-50. doi: 10.1016/s0304-3940(02)00016-2. Neurosci Lett. 2002. PMID: 11852183

8

Parkin accumulation in aggresomes due to proteasome impairment.

Junn E, Lee SS, Suhr UT, Mouradian MM. Junn E, et al. J Biol Chem. 2002 Dec 6;277(49):47870-7. doi: 10.1074/jbc.M203159200. Epub 2002 Oct 2. J Biol Chem. 2002. PMID: 12364339 Free article.

9

Synphilin-1 degradation by the ubiquitin-proteasome pathway and effects on cell survival.

Lee G, Junn E, Tanaka M, Kim YM, Mouradian MM. Lee G, et al. Among authors: junn e. J Neurochem. 2002 Oct;83(2):346-52. doi: 10.1046/j.1471-4159.2002.01136.x. J Neurochem. 2002. PMID: 12423244 Free article.

10

Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies.

Junn E, Ronchetti RD, Quezado MM, Kim SY, Mouradian MM. Junn E, et al. Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2047-52. doi: 10.1073/pnas.0438021100. Epub 2003 Feb 7. Proc Natl Acad Sci U S A. 2003. PMID: 12576551 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters